Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301143374> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4301143374 endingPage "14" @default.
- W4301143374 startingPage "909" @default.
- W4301143374 abstract "Fibrin D-Dimer (D-Di), prothrombin activation fragment (F 1+2) and thrombin-antithrombin III complexes (TAT) were measured using ELISA procedures in the plasma of patients with an acute deep venous thrombosis (DVT), at presentation and on days 2, 6 and 10 after initiation of heparin treatment. Patients were randomly allocated into two treatment groups: 44 patients received adapted doses of continuous intravenous unfractionated heparin (UH) whereas 47 received 1 mg/kg every twelve hours of a low molecular weight heparin (enoxaparin) subcutaneously. A phlebography and a perfusion lung scan were performed before inclusion and on day 10. Failure of therapy (n = 9) was defined by venogram worsening or confirmed pulmonary embolism. Improvement (n = 44) or stationary state (n = 38) were defined by venogram evolution in the absence of new leg scan defects. At presentation, D-Di, F 1+2 and TAT were above cut-off values in 97, 66 and 89% of patients respectively. D-Di levels correlated with the extent of venous thrombosis whereas TAT and F 1+2 did not. Mean levels of D-Di decreased sharply during the first days of treatment but were still abnormal on day 10. A secondary increase of D-Di on days 6 or 10 by more than 3 micrograms/ml occurred in 4 of the 9 patients who developed a thromboembolic recurrence but in none of the 72 patients who had a more favorable outcome. F 1+2 and TAT time-courses were not related to clinical evolution. In the Enoxaparin group, there was no relationship between antifactor Xa activities and any biological markers.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W4301143374 created "2022-10-04" @default.
- W4301143374 date "1993-12-20" @default.
- W4301143374 modified "2023-09-29" @default.
- W4301143374 title "Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group." @default.
- W4301143374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8165610" @default.
- W4301143374 hasPublicationYear "1993" @default.
- W4301143374 type Work @default.
- W4301143374 citedByCount "7" @default.
- W4301143374 countsByYear W43011433742014 @default.
- W4301143374 countsByYear W43011433742018 @default.
- W4301143374 countsByYear W43011433742022 @default.
- W4301143374 crossrefType "journal-article" @default.
- W4301143374 hasConcept C126322002 @default.
- W4301143374 hasConcept C141071460 @default.
- W4301143374 hasConcept C203014093 @default.
- W4301143374 hasConcept C2776265017 @default.
- W4301143374 hasConcept C2776884760 @default.
- W4301143374 hasConcept C2777557582 @default.
- W4301143374 hasConcept C2778959117 @default.
- W4301143374 hasConcept C2779026020 @default.
- W4301143374 hasConcept C2779519742 @default.
- W4301143374 hasConcept C2780011451 @default.
- W4301143374 hasConcept C2780868729 @default.
- W4301143374 hasConcept C42219234 @default.
- W4301143374 hasConcept C54173615 @default.
- W4301143374 hasConcept C71924100 @default.
- W4301143374 hasConcept C90924648 @default.
- W4301143374 hasConceptScore W4301143374C126322002 @default.
- W4301143374 hasConceptScore W4301143374C141071460 @default.
- W4301143374 hasConceptScore W4301143374C203014093 @default.
- W4301143374 hasConceptScore W4301143374C2776265017 @default.
- W4301143374 hasConceptScore W4301143374C2776884760 @default.
- W4301143374 hasConceptScore W4301143374C2777557582 @default.
- W4301143374 hasConceptScore W4301143374C2778959117 @default.
- W4301143374 hasConceptScore W4301143374C2779026020 @default.
- W4301143374 hasConceptScore W4301143374C2779519742 @default.
- W4301143374 hasConceptScore W4301143374C2780011451 @default.
- W4301143374 hasConceptScore W4301143374C2780868729 @default.
- W4301143374 hasConceptScore W4301143374C42219234 @default.
- W4301143374 hasConceptScore W4301143374C54173615 @default.
- W4301143374 hasConceptScore W4301143374C71924100 @default.
- W4301143374 hasConceptScore W4301143374C90924648 @default.
- W4301143374 hasIssue "6" @default.
- W4301143374 hasLocation W43011433741 @default.
- W4301143374 hasOpenAccess W4301143374 @default.
- W4301143374 hasPrimaryLocation W43011433741 @default.
- W4301143374 hasRelatedWork W1585004555 @default.
- W4301143374 hasRelatedWork W1976801352 @default.
- W4301143374 hasRelatedWork W1986797161 @default.
- W4301143374 hasRelatedWork W1988855938 @default.
- W4301143374 hasRelatedWork W1990111999 @default.
- W4301143374 hasRelatedWork W220073818 @default.
- W4301143374 hasRelatedWork W2398553726 @default.
- W4301143374 hasRelatedWork W2406979114 @default.
- W4301143374 hasRelatedWork W2415982798 @default.
- W4301143374 hasRelatedWork W4250628246 @default.
- W4301143374 hasVolume "70" @default.
- W4301143374 isParatext "false" @default.
- W4301143374 isRetracted "false" @default.
- W4301143374 workType "article" @default.